Market Cap 100.72B
Revenue (ttm) 359.05B
Net Income (ttm) 3.30B
EPS (ttm) N/A
PE Ratio 22.50
Forward PE 21.10
Profit Margin 0.92%
Debt to Equity Ratio -9.49
Volume 487,000
Avg Vol 738,780
Day's Range N/A - N/A
Shares Out 123.43M
Stochastic %K 62%
Beta 0.41
Analysts Strong Sell
Price Target $940.94

Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business soluti...

Industry: Medical Distribution
Sector: Healthcare
Phone: 972 446 4800
Address:
6555 State Highway 161, Irving, United States
profit_guru
profit_guru Jan. 13 at 3:59 PM
$MCK - presentation at JPM conference in less than 2 hours…might close above 860 if they raise guidance
0 · Reply
SparkyReturns
SparkyReturns Jan. 13 at 2:55 PM
$ICU Something's up.. us. Biggest sleeper in biotech right now. GL longs. $JNJ $AMGN $MRK $MCK
0 · Reply
profit_guru
profit_guru Jan. 13 at 2:45 PM
$MCK - this will rally lot higher once they raise guidance on JPM health conference today…near term 900…imo
0 · Reply
FRAGMENTS
FRAGMENTS Jan. 12 at 5:06 PM
0 · Reply
ZacksResearch
ZacksResearch Jan. 12 at 2:29 PM
$CAH, $MCK, and $COR are quietly outpacing the market — here’s why! 🚀 🔍 Cardinal Health’s double-digit earnings growth and pending acquisition of Solaris Health signal a robust turnaround with a Zacks Rank #2. 📈 McKesson’s scale drives a 10% revenue jump, and management raised full-year EPS guidance with a Zacks Rank #3. 💡 Cencora’s specialty focus and strategic investments for future growth underpin its Zacks Rank #3. Discover the full breakdown of these under-the-radar winners here 👉 https://www.zacks.com/stock/news/2815489/3-medical-supplies-stocks-that-beat-the-market-despite-macro-headwinds?cid=sm-stocktwits-2-2815489-body-28367&ADID=SYND_STOCKTWITS_TWEET_2_2815489_BODY_28367
0 · Reply
ZacksResearch
ZacksResearch Jan. 12 at 1:29 PM
Three medical supplies stocks beating the market — even with macro pressure mounting 👀 $CAH, $MCK, and $COR are showing how scale, specialty focus, and strong execution can still deliver market-beating returns while macro headwinds pressure the broader space. Want to see what’s driving the outperformance? Full breakdown here 👉 https://www.zacks.com/stock/news/2815489/3-medical-supplies-stocks-that-beat-the-market-despite-macro-headwinds?cid=sm-stocktwits-2-2815489-teaser-28366&ADID=SYND_STOCKTWITS_TWEET_2_2815489_TEASER_28366
0 · Reply
FRAGMENTS
FRAGMENTS Jan. 12 at 12:12 PM
$ANPA CEO SERIES — JUDY FAULKNER When the Rails Are Invisible Most profiles of Judy Faulkner miss the point. Epic isn’t software. It’s where American healthcare clears. Hospitals don’t use Epic because they love it. They use it because breaking it creates risk — legal, clinical, institutional. This piece isn’t about tech. It’s about defaults, governance, and irreversible systems. HERE:https://cundilldeepvalue.substack.com/p/ceo-series-judy-faulkner-when-the $DOCS $MCK $CAH $ABC
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 1:53 PM
$MCK Share Price: $814.26 Contract Selected: Jan 30, 2026 $810 Calls Buy Zone: $26.05 – $32.18 Target Zone: $47.04 – $57.49 Potential Upside: 71% ROI Time to Expiration: 20 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
stannoxane
stannoxane Jan. 8 at 7:07 PM
$MCK 62K sell order
0 · Reply
stannoxane
stannoxane Jan. 8 at 6:37 PM
$MCK wtf !!!!
0 · Reply
Latest News on MCK
Our Top 10 High Growth Dividend Stocks - November 2025

Nov 15, 2025, 8:00 AM EST - 2 months ago

Our Top 10 High Growth Dividend Stocks - November 2025

AL APH AU AVGO BK CINF EME


McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript

Nov 5, 2025, 7:21 PM EST - 2 months ago

McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript


McKesson Corporation Declares Quarterly Dividend

Oct 30, 2025, 8:00 AM EDT - 2 months ago

McKesson Corporation Declares Quarterly Dividend


How to trade the health care break out

Oct 6, 2025, 2:24 PM EDT - 3 months ago

How to trade the health care break out

MRK UNH VEEV XBI XLV


See How McKesson Shares Rise with Money Flows

Oct 1, 2025, 7:28 AM EDT - 3 months ago

See How McKesson Shares Rise with Money Flows


McKesson Corporation (MCK) Analyst/Investor Day Transcript

Sep 23, 2025, 4:53 PM EDT - 4 months ago

McKesson Corporation (MCK) Analyst/Investor Day Transcript


McKesson Announces New Organizational Structure

Sep 18, 2025, 8:00 AM EDT - 4 months ago

McKesson Announces New Organizational Structure


McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript

Aug 6, 2025, 6:43 PM EDT - 5 months ago

McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript


McKesson Defied The Doubters (Including Me)--And Could Do It Again

Jul 26, 2025, 12:52 AM EDT - 6 months ago

McKesson Defied The Doubters (Including Me)--And Could Do It Again


Our Top 10 High Growth Dividend Stocks - July 2025

Jul 19, 2025, 8:00 AM EDT - 6 months ago

Our Top 10 High Growth Dividend Stocks - July 2025

APH AVGO BBVA BK CARR EME FIX


Our Top 10 High Growth Dividend Stocks - June 2025

Jun 21, 2025, 8:00 AM EDT - 7 months ago

Our Top 10 High Growth Dividend Stocks - June 2025

APH AVGO CF CTAS CTVA FIX HWM


McKesson to Host Investor Day on September 23, 2025

Jun 11, 2025, 8:00 AM EDT - 7 months ago

McKesson to Host Investor Day on September 23, 2025


McKesson Corporation Completes Acquisition of Core Ventures

Jun 3, 2025, 8:00 AM EDT - 8 months ago

McKesson Corporation Completes Acquisition of Core Ventures


McKesson: Sustained Rally Backed By Strong Financials

May 18, 2025, 3:40 AM EDT - 8 months ago

McKesson: Sustained Rally Backed By Strong Financials


Our Top 10 High-Growth Dividend Stocks -- May 2025

May 17, 2025, 8:30 AM EDT - 8 months ago

Our Top 10 High-Growth Dividend Stocks -- May 2025

AMH APH AVGO BCS BK BRO CI


McKesson To Spin-Off Its Medical-Surgical Solutions Business

May 15, 2025, 2:05 PM EDT - 8 months ago

McKesson To Spin-Off Its Medical-Surgical Solutions Business


McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript

May 8, 2025, 8:08 PM EDT - 8 months ago

McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript


McKesson to Spin Off Medical-Surgical Company

May 8, 2025, 5:40 PM EDT - 8 months ago

McKesson to Spin Off Medical-Surgical Company


profit_guru
profit_guru Jan. 13 at 3:59 PM
$MCK - presentation at JPM conference in less than 2 hours…might close above 860 if they raise guidance
0 · Reply
SparkyReturns
SparkyReturns Jan. 13 at 2:55 PM
$ICU Something's up.. us. Biggest sleeper in biotech right now. GL longs. $JNJ $AMGN $MRK $MCK
0 · Reply
profit_guru
profit_guru Jan. 13 at 2:45 PM
$MCK - this will rally lot higher once they raise guidance on JPM health conference today…near term 900…imo
0 · Reply
FRAGMENTS
FRAGMENTS Jan. 12 at 5:06 PM
0 · Reply
ZacksResearch
ZacksResearch Jan. 12 at 2:29 PM
$CAH, $MCK, and $COR are quietly outpacing the market — here’s why! 🚀 🔍 Cardinal Health’s double-digit earnings growth and pending acquisition of Solaris Health signal a robust turnaround with a Zacks Rank #2. 📈 McKesson’s scale drives a 10% revenue jump, and management raised full-year EPS guidance with a Zacks Rank #3. 💡 Cencora’s specialty focus and strategic investments for future growth underpin its Zacks Rank #3. Discover the full breakdown of these under-the-radar winners here 👉 https://www.zacks.com/stock/news/2815489/3-medical-supplies-stocks-that-beat-the-market-despite-macro-headwinds?cid=sm-stocktwits-2-2815489-body-28367&ADID=SYND_STOCKTWITS_TWEET_2_2815489_BODY_28367
0 · Reply
ZacksResearch
ZacksResearch Jan. 12 at 1:29 PM
Three medical supplies stocks beating the market — even with macro pressure mounting 👀 $CAH, $MCK, and $COR are showing how scale, specialty focus, and strong execution can still deliver market-beating returns while macro headwinds pressure the broader space. Want to see what’s driving the outperformance? Full breakdown here 👉 https://www.zacks.com/stock/news/2815489/3-medical-supplies-stocks-that-beat-the-market-despite-macro-headwinds?cid=sm-stocktwits-2-2815489-teaser-28366&ADID=SYND_STOCKTWITS_TWEET_2_2815489_TEASER_28366
0 · Reply
FRAGMENTS
FRAGMENTS Jan. 12 at 12:12 PM
$ANPA CEO SERIES — JUDY FAULKNER When the Rails Are Invisible Most profiles of Judy Faulkner miss the point. Epic isn’t software. It’s where American healthcare clears. Hospitals don’t use Epic because they love it. They use it because breaking it creates risk — legal, clinical, institutional. This piece isn’t about tech. It’s about defaults, governance, and irreversible systems. HERE:https://cundilldeepvalue.substack.com/p/ceo-series-judy-faulkner-when-the $DOCS $MCK $CAH $ABC
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 1:53 PM
$MCK Share Price: $814.26 Contract Selected: Jan 30, 2026 $810 Calls Buy Zone: $26.05 – $32.18 Target Zone: $47.04 – $57.49 Potential Upside: 71% ROI Time to Expiration: 20 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
stannoxane
stannoxane Jan. 8 at 7:07 PM
$MCK 62K sell order
0 · Reply
stannoxane
stannoxane Jan. 8 at 6:37 PM
$MCK wtf !!!!
0 · Reply
GettnFibbywIT
GettnFibbywIT Jan. 7 at 2:59 PM
0 · Reply
GettnFibbywIT
GettnFibbywIT Jan. 6 at 7:55 PM
$MCK $XLV $SPY MCK - a little momentum has been creeping in (so far) today, with levels above to still monitor closely should price continue moving/closing above - along with momentum continuing to build. Of note, earnings are 2/4/25 and "could" see some pre-earnings buying interest 1-2 weeks prior with implied volatility increasing into that date, which often "can be" favorable to directional option traders (with IV being a component of option premium pricing - all other things being equal). Conversely, a break/close below upward diagonal support would be "heads" up - along with fading momentum, and especially should price make lower lows while moving below the 38.2% fib retracement level:
0 · Reply
GettnFibbywIT
GettnFibbywIT Jan. 6 at 4:28 PM
$MCK $XLV $SPY MCK - McKesson Bulls are definitely going to want a bounce around here, with more momentum coming in underneath, and a continued move/close back above the 23.6% fib retracement ($835 ish) of the entire Aug -Nov '25 upward bullish move:
0 · Reply
cynicaloptimist
cynicaloptimist Jan. 6 at 12:19 AM
Things I'm liking for the year(so far), $MCK $VSEC $FN $CIEN $DEC
0 · Reply
ZacksResearch
ZacksResearch Jan. 5 at 8:15 PM
$MCK surges with a strong Q2 — what’s fueling the growth engine? 🚀 📈 39% YoY rise in adjusted EPS to $9.86 💊 Oncology & Multispecialty segment: 32% revenue growth, 71% operating profit surge 🔧 Tech and automation investments drive efficiency Discover what sets MCK apart in healthcare services 👉 https://www.zacks.com/stock/news/2812001/mckesson-builds-earnings-momentum-on-specialty-and-automation?cid=sm-stocktwits-2-2812001-body-27424&ADID=SYND_STOCKTWITS_TWEET_2_2812001_BODY_27424
0 · Reply
ZacksResearch
ZacksResearch Jan. 5 at 7:15 PM
$MCK earnings momentum is building fast — and this quarter proved it. McKesson delivered a strong fiscal second quarter, raised its full-year EPS outlook, and showed how specialty growth and automation are driving a step-change in earnings power 📈 See how this shift is reshaping the McKesson story 👉 https://www.zacks.com/stock/news/2812001/mckesson-builds-earnings-momentum-on-specialty-and-automation?cid=sm-stocktwits-2-2812001-teaser-27423&ADID=SYND_STOCKTWITS_TWEET_2_2812001_TEASER_27423
0 · Reply
SparkyReturns
SparkyReturns Jan. 2 at 8:11 PM
$ICU Nothing to see here, LOL. Just an 8M MC, Cash on hand of $ 10-11 M, and TAM of 20B, That's all. RS on Monday Jan 5 already baked in. Unreal. I'll keep loading. $AMGN $BAX $JNJ $MCK
2 · Reply
stannoxane
stannoxane Dec. 31 at 10:23 PM
$MCK what happened here?
0 · Reply
RinaGuerrera510
RinaGuerrera510 Dec. 31 at 5:31 PM
$BN $HOOD $MELI $MCK $CVS Very compelling
0 · Reply
Carmenfean
Carmenfean Dec. 24 at 5:05 PM
$HOOD $ADP $BN $ENB $MCK What a news!
0 · Reply
LongStraddleL
LongStraddleL Dec. 24 at 4:08 PM
$MCK Capital markets will reward execution consistency across macro cycles and demand regimes, with outcomes shaped by timing and discipline. Failure to deliver could compress multiples quickly.
0 · Reply
SparkyReturns
SparkyReturns Dec. 22 at 5:21 PM
$ICU Dammit I should keep quiet. Now I gotta chase it to get more shares. This device will be a game-changer for kidney disease, sepsis, cardio-renal, and any disease with hyper-inflammation and cytokine storm. GL longs! $DVA $BAX $MCK $BDX
0 · Reply